Your browser doesn't support javascript.
loading
Mendelian randomisation study of smoking exposure in relation to breast cancer risk.
Park, Hanla A; Neumeyer, Sonja; Michailidou, Kyriaki; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Ahearn, Thomas U; Andrulis, Irene L; Anton-Culver, Hoda; Antonenkova, Natalia N; Arndt, Volker; Aronson, Kristan J; Augustinsson, Annelie; Baten, Adinda; Beane Freeman, Laura E; Becher, Heiko; Beckmann, Matthias W; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Bogdanova, Natalia V; Bojesen, Stig E; Brauch, Hiltrud; Brenner, Hermann; Brucker, Sara Y; Burwinkel, Barbara; Campa, Daniele; Canzian, Federico; Castelao, Jose E; Chanock, Stephen J; Chenevix-Trench, Georgia; Clarke, Christine L; Conroy, Don M; Couch, Fergus J; Cox, Angela; Cross, Simon S; Czene, Kamila; Daly, Mary B; Devilee, Peter; Dörk, Thilo; Dos-Santos-Silva, Isabel; Dwek, Miriam; Eccles, Diana M; Eliassen, A Heather; Engel, Christoph; Eriksson, Mikael; Evans, D Gareth; Fasching, Peter A; Flyger, Henrik; Fritschi, Lin.
Afiliación
  • Park HA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Neumeyer S; Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
  • Michailidou K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bolla MK; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Wang Q; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn TU; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Anton-Culver H; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Antonenkova NN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Arndt V; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Aronson KJ; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Augustinsson A; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
  • Baten A; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Beane Freeman LE; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Becher H; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
  • Beckmann MW; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
  • Behrens S; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Benitez J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Bermisheva M; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bogdanova NV; Institute of Biometry and Clinical Epidemiology, Charité -Universitätsmedizin Berlin, Berlin, Germany.
  • Bojesen SE; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Brauch H; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brenner H; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Brucker SY; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Burwinkel B; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Campa D; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Canzian F; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Castelao JE; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Chanock SJ; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Chenevix-Trench G; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Clarke CL; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Conroy DM; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.
  • Couch FJ; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
  • Cox A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Czene K; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Daly MB; Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany.
  • Devilee P; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dörk T; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
  • Dos-Santos-Silva I; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dwek M; Department of Biology, University of Pisa, Pisa, Italy.
  • Eccles DM; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Eliassen AH; Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • Engel C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Eriksson M; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Evans DG; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
  • Flyger H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Fritschi L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Br J Cancer ; 125(8): 1135-1145, 2021 10.
Article en En | MEDLINE | ID: mdl-34341517

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Polimorfismo de Nucleótido Simple / Fumar Cigarrillos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Polimorfismo de Nucleótido Simple / Fumar Cigarrillos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Alemania